Latvian biotech, pharmaceutical and biomedical companies will take part in Swiss Biotech Day 2026, one of Europe’s leading life sciences partnering events, taking place in Basel, Switzerland, from 4 to 6 May 2026.
The Latvian delegation brings together innovative SMEs, scale-ups and established companies active across the biomedical value chain — including drug development, advanced therapies, diagnostics, biotech services, and health technologies. During the event, Latvian companies will present their solutions, explore partnerships, and engage in targeted B2B meetings with international industry players, investors, and research organisations.
Swiss Biotech Day annually gathers more than 3,000 participants from over 50 countries, offering a strong platform for international collaboration, technology scouting, licensing discussions, and joint R&D opportunities. Switzerland is one of the world’s strongest life sciences hubs, making the event a key meeting point for global biotech cooperation.
Where to meet Latvian companies
- Latvian national stand at Swiss Biotech Day
- Pre-arranged B2B meetings and networking sessions
- Startup pitch sessions (for selected companies)
- International delegation events and receptions
Extended collaboration opportunities
Following Swiss Biotech Day, Latvian companies will also participate in international matchmaking and innovation cooperation activities in Switzerland, including engagements connected to EUREKA and Innosuisse initiatives, opening additional pathways for joint R&D projects and cross-border innovation.
Why connect with Latvian biotech companies?
- Strong expertise in biomedicine, pharmaceuticals, and applied biotechnology
- Competitive, science-driven SMEs with EU market access
- Experience in international R&D collaboration
- Flexible and partnership-oriented business culture
We warmly invite industry partners, investors, researchers, and innovators to meet Latvian companies in Basel and explore collaboration opportunities.
The participation of Latvian SMEs is supported through an EU and Latvian state co-funded programme aimed at strengthening innovative small and medium-sized enterprises and their international competitiveness.
